Primary aldosteronism and essential hypertension: Assessment of cardiovascular risk at diagnosis and after treatment

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 24, Issue 5, 2014, Pages 476-482

  Turchi, F ^a,b   Ronconi, V ^a   Di Tizio, V ^a   Ceccoli, L ^a   Boscaro, M ^a   Giacchetti, G ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

Author keywords

Adrenal gland; Cardiovascular risk; Primary aldosteronism

Indexed keywords

ALDOSTERONE; CHOLESTEROL; CREATININE; GLUCOSE; HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; GLUCOSE BLOOD LEVEL;

ABDOMINAL OBESITY; ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CARDIOVASCULAR RISK; ECHOCARDIOGRAPHY; ECHOGRAPHY; ESSENTIAL HYPERTENSION; FEMALE; GLYCEMIC INDEX; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MICROALBUMINURIA; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING; AGED; BLOOD; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; COMPLICATION; FOLLOW UP; GLUCOSE BLOOD LEVEL; HYPERALDOSTERONISM; HYPERTENSION; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PROSPECTIVE STUDY;

ADULT; AGED; ALDOSTERONE; BLOOD GLUCOSE; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERALDOSTERONISM; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 84898814285     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2013.09.009     Document Type: Article

References (23)

1. Funder J.W., Carey R.M., Fardella C., Gomez-Sanchez C.E., Mantero F., Stowasser M., et al. 2008 Case detection, diagnosis and treatment of patients with primary aldosteronism: an Endocrine Society Clinical Practice Guidelines. J Clin Endocrinol Metab 2008, 93:3266-3281.
2. Rossi G.P., Sechi L.A., Giacchetti G., Ronconi V., Strazzullo P., Funder J.W. Primary aldosteronism: cardiovascular, renal and metabolic implications. Trends Endocrinol Metab 2008, 19:88-90.
3. Milliez P., Girerd X., Plouin P.F., Blacher J., Safar M.E., Mourad J.J. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 2005, 45(8):1243-1248. 19.
4. Catena C., Colussi G., Nadalini E., Chiuch A., Baroselli S., Lapenna R., et al. Cardiovascular outcomes in patients with primary aldosteronism after treatment. Arch Intern Med 2008, 168(1):80-85. 14.
5. Savard S., Amar L., Plouin P.F., Steichen O. Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study. Hypertension 2013, 62(2):331-336.
6. Born-Frontsberg E., Reincke M., Rump L.C., Hahner S., Diederich S., Lorenz R., et al. Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German Conn's Registry. J Clin Endocrinol Metab 2009, 94:1125-1130. for the participants of the German Conn's Registry.
7. Giacchetti G., Ronconi V., Lucarelli G., Boscaro M., Mantero F. Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism: need for a standardized protocol. J Hypertens 2006, 24(4):737-745.
8. Guidelines Committee European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2007, 25:1105-1187.
9. Devereux R.B. Detection of left ventricular hypertrophy by M-mode echocardiography: anatomic validation, standardization, and comparison to other methods. Hypertension 1987, 9(Suppl. II):II-19-II-26.
10. Rossi G.P., Sacchetto A., Pavan E., Palatini P., Graniero R., Canali C., et al. Remodeling of the left ventricle in primary aldosteronism due to Conn's adenoma. Circulation 1997, 95:1471-1478.
11. Giacchetti G., Ronconi V., Turchi F., Agostinelli L., Mantero M., Rilli S., et al. Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study. J Hypertens 2007, 25:177-186.
12. Catena C., Lapenna R., Caroselli S., Nadalini E., Colussi G., Novello M., et al. Insulin sensitivity in patients with primary aldosteronism: a follow up study. J Clin Endocrinol Metab 2006, 91:3457-3463.
13. Fallo F., Veglio F., Bertello C., Sonino N., Della Mea P., Ermani M., et al. Prevalence and characteristics of the metabolic syndrome in primary aldosteronism. J Clin Endocrinol Metab 2006, 91:454-459.
14. Ronconi V., Turchi F., Rilli S., Di Mattia D., Agostinelli L., Boscaro M., et al. Metabolic syndrome in primary aldosteronism and essential hypertension: relationship to adiponectin gene variants. Nutr Metab Cardiovasc Dis 2010, 20:93-100.
15. Fallo F., Della Mea P., Sonino N., Bertello C., Ermani M., Vettor R., et al. Adiponectin and insulin sensitivity in primary aldosteronism. Am J Hypertens 2007, 20:855-861.
16. Catena C., Colussi G., Lapenna R., Nadalini E., Chiuch A., Gianfagna P., et al. Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonist in patients with primary aldosteronism. Hypertension 2007, 50:911-918.
17. Rossi G.P., Sacchetto A., Visentin P., Canali C., Graniero G.R., Palatini P., et al. Changes in left ventricular anatomy and function in hypertension and primary aldosteronism. Hypertension 1996, 27:1039-1045.
18. Rossi G.P., Di Bello V., Ganzaroli C., Sacchetto A., Cesari M., Bertini A., et al. Excess aldosterone is associated with alteration of myocardial texture in primary aldosteronism. Hypertension 2002, 40:23-27.
19. Muiesan M.L., Salvetti M., Paini A., Agabiti-Rosei C., Monteduro C., Galbassini G., et al. Inappropriate left ventricular mass in patients with primary aldosteronism. Hypertension 2008, 52:529-534.
20. Rossi G.P., Cesari M., Cuspidi C., Maiolino G., Cicala M.V., Bisogni V., et al. Long-term control of arterial hypertension and regression of left ventricular hypertrophy with treatment of primary aldosteronism. Hypertension 2013, 62(1):62-69.
21. Bernini G., Bacca A., Carli V., Carrara D., Materazzi G., Berti P., et al. Cardiovascular changes in patients with primary aldosteronism after surgical or medical treatment. J Endocrinol Invest 2012, 35(3):274-280.
22. Sindelka G., Widimský J., Haas T., Prázný M., Hilgertová J., Skrha J. Insulin action in primary aldosteronism before and after surgical or pharmacological treatment. Exp Clin Endocrinol Diabetes 2000, 108:21-25.
23. Shimamoto K., Shiiki M., Ise T., Miyazaki Y., Higashiura K., Fukuoka M., et al. Does insulin resistance participate in an impaired glucose tolerance in primary aldosteronism?. J Hum Hypertens 1994, 10:755-759.